Personalis, Inc.
- PSNL
- NASDAQ
- Medical - Diagnostics & Research
- Cancer Genomics
- Sequencing/Data Analysis
- Precision Diagnostics
$15.65
Today −1.76%Quote Oct 16, 2026, 08:00 PM UTC
−3.57%over the last month
Max drawdown −5.6%From 1-month high −5.6%3 months +17.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.67B
Quote Oct 16
Next earnings
Nov 3
Expected, not confirmed
Analyst target
$14.95
−4.5% from here
Floor
$15.59
0.4% below price
Where the price sits
12 analysts
Analyst range, low to high
$9.00$17.00
- Price $15.65
- Resistance $15.98–$16.14
- Consensus $14.95
The price is just above its floor and right under resistance. Analysts' average target sits about 4% lower. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PSNLPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Medical - Diagnostics & Research
Employees
260
Founded
2011